Compare MDGL & PNFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDGL | PNFP |
|---|---|---|
| Founded | 2011 | 2000 |
| Country | United States | United States |
| Employees | N/A | 3595 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 13.3B |
| IPO Year | 2005 | N/A |
| Metric | MDGL | PNFP |
|---|---|---|
| Price | $508.53 | $98.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 17 |
| Target Price | ★ $674.45 | $113.31 |
| AVG Volume (30 Days) | 262.9K | ★ 1.3M |
| Earning Date | 05-06-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.05% |
| EPS Growth | ★ 41.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $180,133,000.00 | N/A |
| Revenue This Year | $58.39 | $160.52 |
| Revenue Next Year | $48.55 | $9.24 |
| P/E Ratio | ★ N/A | $12.24 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $284.02 | $81.08 |
| 52 Week High | $615.00 | $120.39 |
| Indicator | MDGL | PNFP |
|---|---|---|
| Relative Strength Index (RSI) | 53.75 | 56.28 |
| Support Level | $498.59 | $92.75 |
| Resistance Level | $540.72 | $100.91 |
| Average True Range (ATR) | 17.55 | 2.73 |
| MACD | 3.74 | 0.18 |
| Stochastic Oscillator | 70.79 | 85.41 |
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.